<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ticlopidin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:10 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Ticlopidin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Ticlopidin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Ticlopidin_files/filelist.xml">
<title>TICLOPIDIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:11:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:30:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>2156</o:Words>
  <o:Characters>12292</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>102</o:Lines>
  <o:Paragraphs>28</o:Paragraphs>
  <o:CharactersWithSpaces>14420</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>TICLOPIDIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Ticlopidine.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> B01A C05.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Thu&#7889;c
kháng ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Viên bao phim 250 mg (ticlopidin hydroclorid). <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin, d&#7851;n ch&#7845;t thienopyridin, là thu&#7889;c &#7913;c
ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u, làm suy gi&#7843;m ch&#7913;c
n&#259;ng ti&#7875;u c&#7847;u b&#7857;ng cách gây tr&#7841;ng thái gi&#7889;ng
nh&#432; nh&#432;&#7907;c ti&#7875;u c&#7847;u. Thu&#7889;c t&#432;&#417;ng tác
v&#7899;i glycoprotein IIb/IIIa c&#7911;a ti&#7875;u c&#7847;u &#273;&#7875; &#7913;c
ch&#7871; fibrinogen liên k&#7871;t v&#7899;i ti&#7875;u c&#7847;u ho&#7841;t
hóa. Glycoprotein IIb/IIIa là th&#7909; th&#7875; c&#7911;a fibrinogen liên k&#7871;t
ti&#7875;u c&#7847;u b&#7857;ng fibrinogen &#273;&#7875; t&#7841;o nên nút k&#7871;t
t&#7909;; tác d&#7909;ng này làm co c&#7909;c máu &#273;ông. Nh&#432; v&#7853;y,
ticlopidin &#7913;c ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u và co c&#7909;c
&#273;ông máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ticlopidin kéo dài th&#7901;i gian ch&#7843;y
máu, có tác d&#7909;ng t&#7889;i &#273;a sau m&#7897;t s&#7889; ngày &#273;i&#7873;u
tr&#7883;; ch&#7913;c n&#259;ng b&#7845;t th&#432;&#7901;ng c&#7911;a ti&#7875;u
c&#7847;u còn kéo dài trong m&#7897;t s&#7889; ngày sau khi ng&#7915;ng &#273;i&#7873;u
tr&#7883;. Có th&#7875; m&#7897;t ch&#7845;t chuy&#7875;n hóa nào &#273;ó c&#7911;a
ticlopidin là ch&#7845;t có ho&#7841;t tính ch&#7889;ng huy&#7871;t kh&#7889;i,
vì thu&#7889;c t&#432;&#417;ng &#273;&#7889;i không có hi&#7879;u qu&#7843; &#7913;c
ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u khi cho vào ti&#7875;u c&#7847;u
in vitro, so v&#7899;i tác d&#7909;ng trên ti&#7875;u c&#7847;u l&#7845;y t&#7915;
ng&#432;&#7901;i b&#7879;nh &#273;ã u&#7889;ng thu&#7889;c này.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>&#7902; ng&#432;&#7901;i kho&#7867; m&#7841;nh trên 50 tu&#7893;i,
&#273;ã phát hi&#7879;n có &#7913;c ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u
&#273;áng k&#7875; (trên 50%) do adenosin diphosphat trong vòng 4 ngày sau khi
dùng ticlopidin hydroclorid 250 mg, ngày 2 l&#7847;n, và &#273;&#7841;t t&#7889;i
&#273;a (60 - 70%) sau 8 &#273;&#7871;n 11 ngày. Li&#7873;u th&#7845;p h&#417;n
gây &#7913;c ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u ít h&#417;n và
ch&#7853;m h&#417;n, còn nh&#7919;ng li&#7873;u trên 250 mg, ngày 2 l&#7847;n
làm t&#259;ng tác d&#7909;ng thêm chút ít, nh&#432;ng l&#7841;i t&#259;ng t&#7927;
l&#7879; tác d&#7909;ng không mong mu&#7889;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau khi ng&#7915;ng ticlopidin, th&#7901;i gian ch&#7843;y máu và nh&#7919;ng
th&#7917; nghi&#7879;m khác v&#7873; ch&#7913;c n&#259;ng ti&#7875;u c&#7847;u
tr&#7903; v&#7873; bình th&#432;&#7901;ng trong vòng 2 tu&#7847;n &#7903; ph&#7847;n
l&#7899;n ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong th&#7917; nghi&#7879;m lâm sàng &#7903; nh&#7919;ng ng&#432;&#7901;i
có các d&#7845;u hi&#7879;u báo tr&#432;&#7899;c c&#7911;a &#273;&#7897;t qu&#7925;,
ticlopidin làm gi&#7843;m nguy c&#417; &#273;&#7897;t q&#7909;y gây ho&#7863;c
không gây t&#7917; vong trong th&#7901;i gian nghiên c&#7913;u ít nh&#7845;t 2
&#273;&#7871;n 5 n&#259;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong th&#7917; nghi&#7879;m lâm sàng &#7903; nh&#7919;ng ng&#432;&#7901;i
&#273;ã có &#273;&#7897;t qu&#7925; tr&#432;&#7899;c do v&#7919;a &#273;&#7897;ng
m&#7841;ch - huy&#7871;t kh&#7889;i, ticlopidin làm gi&#7843;m có ý ngh&#297;a
nguy c&#417; toàn th&#7875; c&#7911;a &#273;&#7897;t qu&#7925; trong th&#7901;i
gian nghiên c&#7913;u 3 n&#259;m. Hi&#7879;n nay, ticlopidin &#273;&#432;&#7907;c
dùng &#273;&#7875; d&#7921; phòng huy&#7871;t kh&#7889;i trong nh&#7919;ng b&#7879;nh
v&#7873; m&#7841;ch máu não và &#273;&#7897;ng m&#7841;ch vành. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin là thu&#7889;c gây nhi&#7873;u r&#7911;i ro và r&#7845;t
&#273;&#7897;c. Th&#7847;y thu&#7889;c &#273;a khoa không &#273;&#432;&#7907;c
dùng thu&#7889;c này, mà ph&#7843;i do th&#7847;y thu&#7889;c chuyên khoa. Ph&#7843;i
&#273;ánh giá &#273;&#7847;y &#273;&#7911; tình tr&#7841;ng máu g&#7891;m c&#7843;
&#273;&#7871;m ti&#7875;u c&#7847;u và công th&#7913;c b&#7841;ch c&#7847;u,
tr&#432;&#7899;c khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883;, r&#7891;i
sau &#273;ó c&#7913; 2 tu&#7847;n m&#7897;t l&#7847;n trong 3 tháng &#273;&#7847;u,
t&#7915; khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883; v&#7899;i
ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ph&#7843;i ng&#7915;ng ticlopidin ngay trong
tr&#432;&#7901;ng h&#7907;p có gi&#7843;m b&#7841;ch c&#7847;u trung tính
(d&#432;&#7899;i 1.500 b&#7841;ch c&#7847;u trung tính/mm<sup>3</sup>) ho&#7863;c
gi&#7843;m ti&#7875;u c&#7847;u (d&#432;&#7899;i 100.000/mm<sup>3</sup>). C&#361;ng
ph&#7843;i làm xét nghi&#7879;m máu trong vòng 2 tu&#7847;n sau khi ng&#7915;ng
&#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ph&#7843;i ng&#7915;ng ticlopidin ngay trong
tr&#432;&#7901;ng h&#7907;p viêm h&#7885;ng, loét mi&#7879;ng, xu h&#432;&#7899;ng
ch&#7843;y máu b&#7845;t th&#432;&#7901;ng, ch&#7843;y máu da nh&#7865; ho&#7863;c
phân &#273;en. Ph&#7843;i ng&#7915;ng &#273;i&#7873;u tr&#7883; khi có vàng da.
Không &#273;&#432;&#7907;c ti&#7871;p t&#7909;c &#273;i&#7873;u tr&#7883; cho t&#7899;i
khi lo&#7841;i tr&#7915; &#273;&#432;&#7907;c ch&#7913;ng gi&#7843;m b&#7841;ch
c&#7847;u ho&#7863;c gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi có ban xu&#7845;t huy&#7871;t do gi&#7843;m ti&#7875;u c&#7847;u
huy&#7871;t kh&#7889;i thì nên &#273;i&#7873;u tr&#7883; cho ng&#432;&#7901;i b&#7879;nh
b&#7857;ng huy&#7871;t t&#432;&#417;ng t&#432;&#417;i giàu ti&#7875;u c&#7847;u.
Không &#273;&#432;&#7907;c dùng &#273;&#7891;ng th&#7901;i ticlopidin v&#7899;i
nh&#7919;ng thu&#7889;c khác có tác &#273;&#7897;ng &#273;&#7871;n &#273;ông
máu (heparin, thu&#7889;c ch&#7889;ng &#273;ông máu u&#7889;ng ho&#7863;c thu&#7889;c
ch&#7889;ng viêm không steroid).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ðã có báo cáo ch&#7843;y máu gây t&#7917; vong là bi&#7871;n ch&#7913;ng
c&#7911;a li&#7879;u pháp ph&#7889;i h&#7907;p. Ph&#7843;i ng&#7915;ng &#273;i&#7873;u
tr&#7883; ticlopidin ít nh&#7845;t m&#7897;t tu&#7847;n tr&#432;&#7899;c khi ph&#7851;u
thu&#7853;t. N&#7871;u c&#7847;n ph&#7843;i m&#7893; kh&#7849;n c&#7845;p, có
th&#7875; h&#7841;n ch&#7871; nguy c&#417; ch&#7843;y máu b&#7857;ng
methylprednisolon 0,5 - 1 mg/kg, tiêm t&#297;nh m&#7841;ch (có th&#7875; tiêm l&#7863;p
l&#7841;i), desmopressin 0,2 - 0,4 microgam/kg tiêm t&#297;nh m&#7841;ch ho&#7863;c
b&#7857;ng truy&#7873;n ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau khi u&#7889;ng m&#7897;t li&#7873;u duy nh&#7845;t 250 mg,
ticlopidin &#273;&#432;&#7907;c h&#7845;p thu nhanh và &#273;&#7841;t n&#7891;ng
&#273;&#7897; &#273;&#7881;nh huy&#7871;t t&#432;&#417;ng kho&#7843;ng 2 gi&#7901;
sau khi u&#7889;ng và &#273;&#432;&#7907;c chuy&#7875;n hóa m&#7841;nh. H&#7845;p
thu l&#7899;n h&#417;n 80%. U&#7889;ng thu&#7889;c cùng v&#7899;i th&#7913;c
&#259;n làm t&#259;ng 20% di&#7879;n tích d&#432;&#7899;i &#273;&#432;&#7901;ng
cong c&#7911;a ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>&#7902; ng&#432;&#7901;i cao tu&#7893;i, n&#7917;a &#273;&#7901;i c&#7911;a
ticlopidin, sau li&#7873;u duy nh&#7845;t 250 mg, kho&#7843;ng 12,6 gi&#7901;;
dùng thu&#7889;c l&#7863;p l&#7841;i &#7903; li&#7873;u 250 mg, ngày 2 l&#7847;n,
thì n&#7917;a &#273;&#7901;i th&#7843;i tr&#7915; cu&#7889;i cùng t&#259;ng lên
t&#7899;i 4 &#273;&#7871;n 5 ngày và n&#7891;ng &#273;&#7897; ticlopidin trong
huy&#7871;t t&#432;&#417;ng &#273;&#7841;t tr&#7841;ng thái &#7893;n &#273;&#7883;nh
sau kho&#7843;ng 14 &#273;&#7871;n 21 ngày. 98% ticlopidin liên k&#7871;t thu&#7853;n
ngh&#7883;ch v&#7899;i protein huy&#7871;t t&#432;&#417;ng, ch&#7911; y&#7871;u
v&#7899;i albumin và lipoprotein huy&#7871;t thanh. S&#7921; liên k&#7871;t v&#7899;i
albumin và lipoprotein không bão hòa x&#7843;y ra trên m&#7897;t ph&#7841;m vi
n&#7891;ng &#273;&#7897; r&#7897;ng. Ticlopidin còn liên k&#7871;t v&#7899;i
alpha<sub>1</sub> glycoprotein acid. &#7902; n&#7891;ng &#273;&#7897; &#273;&#7841;t
&#273;&#432;&#7907;c v&#7899;i li&#7873;u khuyên dùng, ch&#7881; có 15%, ho&#7863;c
ít h&#417;n, ticlopidin trong huy&#7871;t t&#432;&#417;ng liên k&#7871;t v&#7899;i
protein này.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin chuy&#7875;n hóa m&#7841;nh &#7903; gan, ch&#7881; phát hi&#7879;n
s&#7889; l&#432;&#7907;ng r&#7845;t nh&#7887; thu&#7889;c d&#432;&#7899;i d&#7841;ng
không bi&#7871;n &#273;&#7893;i trong n&#432;&#7899;c ti&#7875;u. Sau khi u&#7889;ng
ticlopidin, 60% li&#7873;u thu&#7889;c có trong n&#432;&#7899;c ti&#7875;u và
23% trong phân. Kho&#7843;ng 1/3 li&#7873;u thu&#7889;c bài ti&#7871;t trong
phân là ticlopidin còn nguyên v&#7865;n, có th&#7875; là &#273;&#432;&#7907;c
bài ti&#7871;t trong m&#7853;t. Kho&#7843;ng 40 - 50% ch&#7845;t chuy&#7875;n
hóa l&#432;u thông trong huy&#7871;t t&#432;&#417;ng liên k&#7871;t &#273;&#7891;ng
hóa tr&#7883; v&#7899;i protein huy&#7871;t t&#432;&#417;ng, có th&#7875; do
acyl - hóa.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7897; thanh th&#7843;i c&#7911;a ticlopidin gi&#7843;m theo tu&#7893;i.
N&#7891;ng &#273;&#7897; &#273;áy &#273;&#7841;t tr&#7841;ng thái &#7893;n
&#273;&#7883;nh &#7903; ng&#432;&#7901;i cao tu&#7893;i (tu&#7893;i trung bình
70) b&#7857;ng kho&#7843;ng g&#7845;p &#273;ôi so v&#7899;i ng&#432;&#7901;i tr&#7867;
tu&#7893;i.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh &#273;&#7875;
làm gi&#7843;m nguy c&#417; &#273;&#7897;t qu&#7925; huy&#7871;t kh&#7889;i &#7903;
ng&#432;&#7901;i b&#7879;nh &#273;ã có &#273;&#7897;t qu&#7925; huy&#7871;t kh&#7889;i
x&#7843;y ra tr&#432;&#7899;c &#273;ó và &#7903; ng&#432;&#7901;i có nh&#7919;ng
d&#7845;u hi&#7879;u báo tr&#432;&#7899;c (ví d&#7909;, c&#417;n thi&#7871;u
máu c&#7909;c b&#7897; nh&#7845;t th&#7901;i, thoáng mù m&#7897;t m&#7855;t ho&#7863;c
mù thoáng qua [amaurosis fugax], r&#7889;i lo&#7841;n th&#7847;n kinh do thi&#7871;u
máu c&#7909;c b&#7897; th&#7847;n kinh có th&#7875; ph&#7909;c h&#7891;i,
&#273;&#7897;t qu&#7925; nh&#7887;).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì ticlopidin có th&#7875; gây gi&#7843;m b&#7841;ch c&#7847;u trung
tính và/ho&#7863;c m&#7845;t b&#7841;ch c&#7847;u h&#7841;t, có th&#7875;
&#273;e d&#7885;a tính m&#7841;ng, nên ph&#7843;i dành ticlopidin &#273;&#7875;
&#273;i&#7873;u tr&#7883; cho nh&#7919;ng ng&#432;&#7901;i không th&#7875; dung
n&#7841;p li&#7879;u pháp v&#7899;i aspirin trong tr&#432;&#7901;ng h&#7907;p
ch&#7881; &#273;&#7883;nh &#273;&#7875; d&#7921; phòng &#273;&#7897;t qu&#7925;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh ticlopidin trong nh&#7919;ng
tr&#432;&#7901;ng h&#7907;p sau:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>T&#7841;ng ch&#7843;y máu, loét d&#7841; dày tá tràng, ch&#7843;y máu
trong s&#7885;, b&#7879;nh v&#7873; máu, gi&#7843;m b&#7841;ch c&#7847;u, gi&#7843;m
ti&#7875;u c&#7847;u, ho&#7863;c m&#7845;t b&#7841;ch c&#7847;u h&#7841;t trong
b&#7879;nh s&#7917; c&#7911;a ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#7883; &#7913;ng v&#7899;i ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>T&#7893;n th&#432;&#417;ng gan n&#7863;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì ticlopidin có th&#7875; gây nh&#7919;ng tác d&#7909;ng không mong
mu&#7889;n &#273;e d&#7885;a tính m&#7841;ng, nên ph&#7843;i cân nh&#7855;c l&#7907;i
ích &#273;i&#7873;u tr&#7883; có tr&#7897;i h&#417;n nguy c&#417; có th&#7875;
x&#7843;y ra, và ph&#7843;i báo cho ng&#432;&#7901;i b&#7879;nh bi&#7871;t v&#7873;
nh&#7919;ng nguy c&#417; &#273;ó. Ph&#7843;i dành ticlopidin cho ng&#432;&#7901;i
không dung n&#7841;p &#273;&#432;&#7907;c aspirin trong ch&#7881; &#273;&#7883;nh
d&#7921; phòng &#273;&#7897;t qu&#7925;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì ticlopidin có th&#7875; gây gi&#7843;m b&#7841;ch c&#7847;u trung
tính nghiêm tr&#7885;ng và/ho&#7863;c m&#7845;t b&#7841;ch c&#7847;u h&#7841;t,
và c&#7843; nh&#7919;ng s&#7921; b&#7845;t th&#432;&#7901;ng v&#7873; huy&#7871;t
h&#7885;c khác có th&#7875; &#273;e d&#7885;a tính m&#7841;ng, c&#7847;n ph&#7843;i
xét nghi&#7879;m t&#7871; bào máu (g&#7891;m c&#7843; &#273;&#7871;m ti&#7875;u
c&#7847;u) và công th&#7913;c b&#7841;ch c&#7847;u tr&#432;&#7899;c khi b&#7855;t
&#273;&#7847;u &#273;i&#7873;u tr&#7883; và c&#7913; 2 tu&#7847;n m&#7897;t l&#7847;n
cho t&#7899;i cu&#7889;i tháng th&#7913; ba c&#7911;a &#273;&#7907;t &#273;i&#7873;u
tr&#7883;. N&#7871;u s&#7889; l&#432;&#7907;ng b&#7841;ch c&#7847;u trung tính
tuy&#7879;t &#273;&#7889;i luôn luôn gi&#7843;m ho&#7863;c th&#7845;p h&#417;n
30% so v&#7899;i ban &#273;&#7847;u, c&#7847;n ph&#7843;i theo dõi th&#432;&#7901;ng
xuyên h&#417;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau ba tháng &#273;&#7847;u &#273;i&#7873;u tr&#7883;, ch&#7881; xét
nghi&#7879;m t&#7871; bào máu &#7903; nh&#7919;ng ng&#432;&#7901;i có d&#7845;u
hi&#7879;u ho&#7863;c tri&#7879;u ch&#7913;ng g&#7907;i ý có nhi&#7877;m khu&#7849;n
ho&#7863;c ch&#7855;c ch&#7855;n là nhi&#7877;m khu&#7849;n. Vì có m&#7897;t s&#7889;
tr&#432;&#7901;ng h&#7907;p gi&#7843;m ti&#7875;u c&#7847;u mi&#7877;n d&#7883;ch
và ban xu&#7845;t huy&#7871;t gi&#7843;m ti&#7875;u c&#7847;u huy&#7871;t kh&#7889;i
&#7903; nh&#7919;ng ng&#432;&#7901;i dùng ticlopidin &#273;ã gây t&#7917; vong,
nên c&#7847;n chú ý c&#7849;n th&#7853;n &#273;&#7871;n ch&#7849;n &#273;oán
&#273;&#7875; h&#432;&#7899;ng d&#7851;n &#273;i&#7873;u tr&#7883;. Vì
ticlopidin có n&#7917;a &#273;&#7901;i huy&#7871;t t&#432;&#417;ng dài, nên ph&#7843;i
xét nghi&#7879;m t&#7871; bào máu (g&#7891;m c&#7843; &#273;&#7871;m ti&#7875;u
c&#7847;u) và làm công th&#7913;c b&#7841;ch c&#7847;u trong ít nh&#7845;t hai
tu&#7847;n sau khi ng&#7915;ng ticlopidin &#7903; b&#7845;t c&#7913; ng&#432;&#7901;i
b&#7879;nh nào ng&#7915;ng thu&#7889;c do b&#7845;t c&#7913; lý do gì trong
vòng 3 tháng &#273;&#7847;u &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì ticlopidin làm t&#259;ng n&#7891;ng &#273;&#7897; cholesterol toàn
ph&#7847;n và triglycerid huy&#7871;t thanh, nên ph&#7843;i th&#7853;n tr&#7885;ng
khi dùng thu&#7889;c cho ng&#432;&#7901;i b&#7879;nh mà nh&#7919;ng tác d&#7909;ng
này có th&#7875; có t&#7847;m quan tr&#7885;ng v&#7873; lâm sàng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#432;a xác &#273;&#7883;nh &#273;&#432;&#7907;c kh&#7843; n&#259;ng
dung n&#7841;p và s&#7921; <span style='letter-spacing:-.1pt'>an toàn c&#7911;a
li&#7879;u pháp dùng ticlopidin &#273;&#7891;ng th&#7901;i v&#7899;i heparin,
nh&#7919;ng thu&#7889;c ch&#7889;ng &#273;ông máu u&#7889;ng, ho&#7863;c nh&#7919;ng
thu&#7889;c tiêu fibrin. N&#7871;u ng&#432;&#7901;i nào &#273;ang dùng b&#7845;t
c&#7913; thu&#7889;c nào trong s&#7889; &#273;ó mà chuy&#7875;n sang &#273;i&#7873;u
tr&#7883; v&#7899;i ticlopidin thì ph&#7843;i ng&#7915;ng nh&#7919;ng thu&#7889;c
này tr&#432;&#7899;c khi dùng ticlopidin.</span><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ph&#7843;i dùng ticlopidin th&#7853;n tr&#7885;ng
&#7903; ng&#432;&#7901;i có nguy c&#417; t&#259;ng ch&#7843;y máu do ch&#7845;n
th&#432;&#417;ng, ph&#7851;u thu&#7853;t ho&#7863;c nh&#7919;ng b&#7879;nh
khác. N&#7871;u d&#7921; ki&#7871;n ti&#7871;n hành ph&#7851;u thu&#7853;t cho
ng&#432;&#7901;i b&#7879;nh &#273;ang dùng ticlopidin mà mu&#7889;n tránh tác d&#7909;ng
&#7913;c ch&#7871; ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u c&#7911;a thu&#7889;c,
thì ph&#7843;i ng&#7915;ng ticlopidin 10 - 14 ngày tr&#432;&#7899;c khi ph&#7851;u
thu&#7853;t &#273;&#7875; gi&#7843;m thi&#7875;u s&#7921; ch&#7843;y máu quá m&#7913;c
do ph&#7851;u thu&#7853;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Vì ticlopidin làm kéo dài th&#7901;i gian ch&#7843;y
máu, ph&#7843;i dùng th&#7853;n tr&#7885;ng thu&#7889;c này &#7903; ng&#432;&#7901;i
có nh&#7919;ng th&#432;&#417;ng t&#7893;n d&#7877; ch&#7843;y máu. Ngoài ra, ph&#7843;i
dùng c&#7849;n th&#7853;n nh&#7919;ng thu&#7889;c có th&#7875; gây nh&#7919;ng
th&#432;&#417;ng t&#7893;n nh&#432; v&#7853;y &#7903; nh&#7919;ng ng&#432;&#7901;i
&#273;ang &#273;i&#7873;u tr&#7883; v&#7899;i ticlopidin. Không &#273;&#432;&#7907;c
dùng &#273;&#7891;ng th&#7901;i ticlopidin và aspirin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì &#273;i&#7873;u tr&#7883; v&#7899;i ticlopidin có th&#7875; làm
t&#259;ng k&#7871;t qu&#7843; xét nghi&#7879;m ch&#7913;c n&#259;ng gan, bao g&#7891;m
phosphatase ki&#7873;m và transaminase trong huy&#7871;t thanh, và hi&#7871;m
khi t&#259;ng bilirubin huy&#7871;t thanh, c&#7847;n theo dõi ch&#7913;c
n&#259;ng gan b&#7857;ng xét nghi&#7879;m ALT (SGPT) và gamma -
glutamyltransferase khi nghi ng&#7901; có r&#7889;i lo&#7841;n ch&#7913;c
n&#259;ng gan, &#273;&#7863;c bi&#7879;t trong 4 tháng &#273;&#7847;u &#273;i&#7873;u
tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;i dùng th&#7853;n tr&#7885;ng ticlopidin &#7903; ng&#432;&#7901;i
có suy th&#7853;n v&#7915;a ho&#7863;c n&#7863;ng, vì có th&#7875; gi&#7843;m
&#273;&#7897; thanh th&#7843;i huy&#7871;t t&#432;&#417;ng, t&#259;ng tr&#7883;
s&#7889; di&#7879;n tích d&#432;&#7899;i &#273;&#432;&#7901;ng cong và kéo dài
th&#7901;i gian ch&#7843;y máu.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#432;a có nh&#7919;ng nghiên c&#7913;u &#273;&#7847;y &#273;&#7911;
và &#273;&#432;&#7907;c ki&#7875;m tra t&#7889;t v&#7873; s&#7917; d&#7909;ng
ticlopidin &#7903; ng&#432;&#7901;i mang thai, do &#273;ó ch&#7881; nên dùng
ticlopidin cho ng&#432;&#7901;i mang thai khi th&#7853;t c&#7847;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin &#273;&#432;&#7907;c phân b&#7889; trong s&#7919;a chu&#7897;t
c&#7889;ng tr&#7855;ng. Ch&#432;a rõ ticlopidin có &#273;&#432;&#7907;c phân b&#7889;
trong s&#7919;a ng&#432;&#7901;i hay không. Vì ticlopidin có th&#7875; có nh&#7919;ng
tác d&#7909;ng không mong mu&#7889;n nghiêm tr&#7885;ng &#7903; tr&#7867; nh&#7887;
bú s&#7919;a m&#7865;, c&#7847;n cân nh&#7855;c xem nên ng&#7915;ng cho bú ho&#7863;c
ng&#7915;ng dùng thu&#7889;c, có tính &#273;&#7871;n t&#7847;m quan tr&#7885;ng
c&#7911;a thu&#7889;c &#273;&#7889;i v&#7899;i ng&#432;&#7901;i m&#7865;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng không mong mu&#7889;n (ADR)</span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng không mong mu&#7889;n x&#7843;y ra t&#432;&#417;ng
&#273;&#7889;i th&#432;&#7901;ng xuyên. Ph&#7847;n l&#7899;n có liên quan
&#273;&#7871;n &#273;&#432;&#7901;ng tiêu hóa. Ph&#7847;n l&#7899;n tác d&#7909;ng
không mong mu&#7889;n là nh&#7865;, nh&#432;ng trên 20% ng&#432;&#7901;i b&#7879;nh
&#273;ã ng&#7915;ng thu&#7889;c vì m&#7897;t tác d&#7909;ng không mong mu&#7889;n,
ch&#7911; y&#7871;u là &#7881;a ch&#7843;y, ban, bu&#7891;n nôn, nôn, &#273;au
d&#7841; dày - ru&#7897;t và gi&#7843;m b&#7841;ch c&#7847;u trung tính. Ph&#7847;n
l&#7899;n tác d&#7909;ng không mong mu&#7889;n x&#7843;y ra trong ti&#7871;n
trình &#273;i&#7873;u tr&#7883;, nh&#432;ng có th&#7875; l&#7841;i x&#7843;y ra
sau nhi&#7873;u tháng. Tác d&#7909;ng không mong mu&#7889;n nghiêm tr&#7885;ng
nh&#7845;t c&#7911;a ticlopidin có liên quan &#273;&#7871;n h&#7879; máu, ch&#7911;
y&#7871;u là gi&#7843;m b&#7841;ch c&#7847;u trung tính, có th&#7875; &#273;e d&#7885;a
tính m&#7841;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Huy&#7871;t h&#7885;c: Gi&#7843;m b&#7841;ch c&#7847;u trung tính
(3%), ban xu&#7845;t huy&#7871;t, ch&#7843;y máu m&#361;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: &#7880;a ch&#7843;y, bu&#7891;n nôn, khó tiêu, &#273;au d&#7841;
dày - ru&#7897;t, nôn, &#273;&#7847;y h&#417;i, chán &#259;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: Ban, mày &#273;ay, ng&#7913;a, ban dát s&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Chóng m&#7863;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gan: Xét nghi&#7879;m ch&#7913;c n&#259;ng gan b&#7845;t th&#432;&#7901;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chuy&#7875;n hóa: T&#259;ng cholesterol huy&#7871;t thanh. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100 <o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Gi&#7843;m b&#7841;ch c&#7847;u trung tính nghiêm tr&#7885;ng
(d&#432;&#7899;i 450/mm<sup>3</sup>) và gi&#7843;m ti&#7875;u c&#7847;u, ch&#7843;y
máu cam.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Ð&#7847;y b&#7909;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: Mày &#273;ay.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tai: Ù tai.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Suy nh&#432;&#7907;c, &#273;au.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt;1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Suy t&#7911;y, m&#7845;t b&#7841;ch c&#7847;u h&#7841;t, thi&#7871;u
máu b&#7845;t s&#7843;n, gi&#7843;m toàn th&#7875; huy&#7871;t c&#7847;u, ban
xu&#7845;t huy&#7871;t gi&#7843;m ti&#7875;u c&#7847;u huy&#7871;t kh&#7889;i.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7871;u lâm sàng và xét nghi&#7879;m xác nh&#7853;n có gi&#7843;m b&#7841;ch
c&#7847;u trung tính (d&#432;&#7899;i 1500 t&#7871; bào/mm<sup>3</sup>) ho&#7863;c
gi&#7843;m ti&#7875;u c&#7847;u (d&#432;&#7899;i 100.000 ti&#7875;u c&#7847;u/mm<sup>3</sup>),
thì ph&#7843;i ng&#7915;ng dùng ticlopidin. Ng&#7915;ng ngay ticlopidin sau khi
phát hi&#7879;n gi&#7843;m b&#7841;ch c&#7847;u trung tính, thì l&#432;&#7907;ng
b&#7841;ch c&#7847;u trung tính th&#432;&#7901;ng tr&#7903; v&#7873; bình
th&#432;&#7901;ng trong vòng 1 - 3 tu&#7847;n, nh&#432;ng c&#361;ng th&#7845;y
có m&#7897;t s&#7889; r&#7845;t ít tr&#432;&#7901;ng h&#7907;p t&#7917; vong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>&#7902; ng&#432;&#7901;i b&#7879;nh có th&#7901;i gian ch&#7843;y máu
kéo dài do &#273;i&#7873;u tr&#7883; ticlopidin, tr&#432;&#7899;c khi ph&#7851;u
thu&#7853;t, tiêm t&#297;nh m&#7841;ch methylprednisolon (20 mg) có th&#7875;
làm th&#7901;i gian ch&#7843;y máu tr&#7903; l&#7841;i bình th&#432;&#7901;ng
trong vòng 2 gi&#7901; sau khi tiêm &#273;&#7875; d&#7921; phòng ch&#7843;y
máu. C&#361;ng có th&#7875; truy&#7873;n ti&#7875;u c&#7847;u &#273;&#7875; h&#7911;y
tác d&#7909;ng c&#7911;a ticlopidin &#273;&#7889;i v&#7899;i ch&#7843;y máu,
nh&#432;ng th&#432;&#7901;ng không ch&#7881; &#273;&#7883;nh truy&#7873;n ti&#7875;u
c&#7847;u cho ng&#432;&#7901;i ban xu&#7845;t huy&#7871;t gi&#7843;m ti&#7875;u
c&#7847;u huy&#7871;t kh&#7889;i th&#7913; phát do &#273;i&#7873;u tr&#7883;
ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Có th&#7875; gi&#7843;m li&#7873;u l&#432;&#7907;ng
ticlopidin ho&#7863;c ng&#7915;ng thu&#7889;c &#7903; ng&#432;&#7901;i có suy
th&#7853;n, n&#7871;u x&#7843;y ra bi&#7871;n ch&#7913;ng ch&#7843;y máu ho&#7863;c
bi&#7871;n ch&#7913;ng v&#7873; t&#7841;o máu,</span><span style='font-size:
9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> d&#7863;n
ng&#432;&#7901;i b&#7879;nh ph&#7843;i báo cáo v&#7899;i th&#7847;y thu&#7889;c
v&#7873; b&#7845;t c&#7913; s&#7921; ch&#7843;y máu không bình th&#432;&#7901;ng
nào<span style='letter-spacing:-.1pt'>.<o:p></o:p></span></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#7863;n ng&#432;&#7901;i b&#7879;nh ph&#7843;i l&#432;u ý &#273;&#7871;n
nh&#7919;ng bi&#7875;u hi&#7879;n nhi&#7877;m khu&#7849;n và g&#7863;p th&#7847;y
thu&#7889;c n&#7871;u th&#7845;y b&#7845;t c&#7913; d&#7845;u hi&#7879;u nào c&#7911;a
nhi&#7877;m khu&#7849;n xu&#7845;t hi&#7879;n ho&#7863;c x&#7845;u &#273;i
trong khi &#273;i&#7873;u tr&#7883; ticlopidin. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cách dùng<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ticlopidin &#273;&#432;&#7907;c dùng u&#7889;ng. Nên u&#7889;ng thu&#7889;c
cùng v&#7899;i th&#7913;c &#259;n &#273;&#7875; t&#259;ng m&#7913;c t&#7889;i
&#273;a h&#7845;p thu &#7903; d&#7841; dày - ru&#7897;t và dung n&#7841;p thu&#7889;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u l&#432;&#7907;ng<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7875; gi&#7843;m nguy c&#417; &#273;&#7897;t qu&#7925; &#7903;
ng&#432;&#7901;i l&#7899;n, li&#7873;u th&#432;&#7901;ng dùng c&#7911;a
ticlopidin là 250 mg, ngày 2 l&#7847;n. S&#7921; an toàn và hi&#7879;u l&#7921;c
c&#7911;a li&#7873;u này &#7903; ng&#432;&#7901;i cao tu&#7893;i gi&#7889;ng
nh&#432; &#7903; ng&#432;&#7901;i l&#7899;n tr&#7867; h&#417;n; tuy nhiên,
không th&#7875; lo&#7841;i tr&#7915; kh&#7843; n&#259;ng có m&#7897;t s&#7889;
ng&#432;&#7901;i cao tu&#7893;i có th&#7875; bi&#7875;u hi&#7879;n t&#259;ng nh&#7841;y
c&#7843;m v&#7899;i ticlopidin. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Antipyrin: </span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ticlopidin &#7913;c ch&#7871;
cytochrom P<sub>450</sub> 2C19. Li&#7873;u &#273;i&#7873;u tr&#7883; c&#7911;a
ticlopidin gây t&#259;ng 30% n&#7917;a &#273;&#7901;i huy&#7871;t
t&#432;&#417;ng c&#7911;a antipyrin và có th&#7875; gây tác d&#7909;ng
t&#432;&#417;ng t&#7921; trên nh&#7919;ng thu&#7889;c chuy&#7875;n hóa
t&#432;&#417;ng t&#7921;. Do &#273;ó, li&#7873;u l&#432;&#7907;ng nh&#7919;ng
thu&#7889;c &#273;&#432;&#7907;c chuy&#7875;n hóa b&#7903;i enzym &#7903;
microsom gan có nh&#7919;ng t&#7927; s&#7889; &#273;i&#7873;u tr&#7883; th&#7845;p
ho&#7863;c &#273;ang dùng cho ng&#432;&#7901;i suy gan có th&#7875; c&#7847;n ph&#7843;i
&#273;i&#7873;u ch&#7881;nh &#273;&#7875; duy trì n&#7891;ng &#273;&#7897;
&#273;i&#7873;u tr&#7883; t&#7889;i &#432;u trong máu khi b&#7855;t &#273;&#7847;u
ho&#7863;c ng&#7915;ng li&#7879;u pháp &#273;&#7891;ng th&#7901;i v&#7899;i
ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Aspirin và thu&#7889;c ch&#7889;ng viêm không steroid khác</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>: Ticlopidin làm t&#259;ng tác d&#7909;ng ng&#432;ng t&#7853;p ti&#7875;u
c&#7847;u c&#7911;a aspirin và nh&#7919;ng thu&#7889;c ch&#7889;ng viêm không
steroid khác. Ch&#432;a xác &#273;&#7883;nh &#273;&#432;&#7907;c tính an toàn
khi dùng &#273;&#7891;ng th&#7901;i ticlopidin v&#7899;i aspirin ho&#7863;c nh&#7919;ng
thu&#7889;c ch&#7889;ng viêm không steroid khác. Aspirin không làm thay &#273;&#7893;i
s&#7921; &#7913;c ch&#7871; do ticlopidin &#273;&#7889;i v&#7899;i ng&#432;ng t&#7853;p
ti&#7875;u c&#7847;u gây b&#7903;i adenosin diphosphat, nh&#432;ng ticlopidin
làm t&#259;ng tác d&#7909;ng ng&#432;ng t&#7853;p ti&#7875;u c&#7847;u do
colagen c&#7911;a aspirin. Không nên dùng &#273;&#7891;ng th&#7901;i aspirin và
ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c kháng acid</span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: N&#7891;ng
&#273;&#7897; ticlopidin trong huy&#7871;t t&#432;&#417;ng sau khi dùng thu&#7889;c
kháng acid gi&#7843;m 18%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cimetidin</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Cimetidin dùng dài ngày làm gi&#7843;m
50% &#273;&#7897; thanh th&#7843;i c&#7911;a m&#7897;t li&#7873;u duy nh&#7845;t
ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Digoxin</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Dùng &#273;&#7891;ng th&#7901;i
ticlopidin v&#7899;i digoxin làm gi&#7843;m nh&#7865; (kho&#7843;ng 15%) n&#7891;ng
&#273;&#7897; huy&#7871;t t&#432;&#417;ng c&#7911;a digoxin. Tác d&#7909;ng
&#273;i&#7873;u tr&#7883; c&#7911;a digoxin ít ho&#7863;c không thay &#273;&#7893;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Theophylin</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Dùng &#273;&#7891;ng th&#7901;i
v&#7899;i ticlopidin làm t&#259;ng có ý ngh&#297;a n&#7917;a &#273;&#7901;i th&#7843;i
tr&#7915; c&#7911;a theophylin t&#7915; 8,6 &#273;&#7871;n 12,2 gi&#7901; và
làm gi&#7843;m &#273;&#7897; thanh th&#7843;i huy&#7871;t t&#432;&#417;ng toàn
ph&#7847;n c&#7911;a theophylin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Phenobarbital</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Dùng phenobarbital dài ngày
không làm thay &#273;&#7893;i tác d&#7909;ng &#7913;c ch&#7871; ng&#432;ng t&#7853;p
ti&#7875;u c&#7847;u c&#7911;a ticlopidin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Phenytoin</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Có m&#7897;t s&#7889; tr&#432;&#7901;ng
h&#7907;p t&#259;ng n&#7891;ng &#273;&#7897; phenytoin trong huy&#7871;t
t&#432;&#417;ng k&#7871;t h&#7907;p v&#7899;i ng&#7911; gà và ng&#7911; l&#7883;m
sau khi dùng k&#7871;t h&#7907;p v&#7899;i ticlopidin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7843;o qu&#7843;n viên nén ticlopidin &#7903; nhi&#7879;t &#273;&#7897;
phòng t&#7915; 15<sup>O</sup>C &#273;&#7871;n 30<sup>O</sup>C.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tri&#7879;u ch&#7913;ng quá li&#7873;u g&#7891;m m&#7845;t &#273;i&#7873;u
hòa, co gi&#7853;t, nôn, &#273;au b&#7909;ng, b&#7845;t th&#432;&#7901;ng v&#7873;
huy&#7871;t h&#7885;c. Không có bi&#7879;n pháp &#273;i&#7873;u tr&#7883;
&#273;&#7863;c hi&#7879;u. Ði&#7873;u tr&#7883; tri&#7879;u ch&#7913;ng và h&#7895;
tr&#7907;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ticlopidin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:10 GMT -->
</html>
